KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medpace Holdings (MEDP) Operating Expenses (2016 - 2026)

Medpace Holdings filings provide 12 years of Operating Expenses readings, the most recent being $565.1 million for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 26.98% to $565.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.1 billion, a 24.41% increase, with the full-year FY2025 number at $2.0 billion, up 20.04% from a year prior.
  • Operating Expenses hit $565.1 million in Q1 2026 for Medpace Holdings, up from $555.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $565.1 million in Q1 2026 to a low of $266.7 million in Q1 2022.
  • Median Operating Expenses over the past 5 years was $411.1 million (2023), compared with a mean of $409.0 million.
  • Biggest five-year swings in Operating Expenses: rose 0.03% in 2024 and later soared 35.01% in 2025.
  • Medpace Holdings' Operating Expenses stood at $317.7 million in 2022, then rose by 29.41% to $411.1 million in 2023, then increased by 0.03% to $411.2 million in 2024, then skyrocketed by 35.01% to $555.2 million in 2025, then grew by 1.79% to $565.1 million in 2026.
  • The last three reported values for Operating Expenses were $565.1 million (Q1 2026), $555.2 million (Q4 2025), and $518.1 million (Q3 2025) per Business Quant data.